INVOS
Device
Medtronic, Inc.
Total Payments
$4.8M
Transactions
5,458
Doctors
3,284
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.7M | 1,313 | 835 |
| 2023 | $981,973 | 852 | 651 |
| 2022 | $143,795 | 713 | 498 |
| 2021 | $54,809 | 1,212 | 748 |
| 2020 | $57,813 | 116 | 99 |
| 2019 | $396,829 | 355 | 287 |
| 2018 | $605,452 | 470 | 362 |
| 2017 | $937,796 | 427 | 333 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.2M | 261 | 87.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $202,057 | 151 | 4.2% |
| Food and Beverage | $162,204 | 4,759 | 3.3% |
| Grant | $119,593 | 50 | 2.5% |
| Travel and Lodging | $68,087 | 188 | 1.4% |
| Consulting Fee | $53,996 | 32 | 1.1% |
| Space rental or facility fees (teaching hospital only) | $8,750 | 9 | 0.2% |
| Long term medical supply or device loan | $7,694 | 8 | 0.2% |
Payments by Type
Research
$4.2M
261 transactions
General
$622,380
5,197 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INVOS CathLab | Medtronic, Inc. | $1.7M | 3 |
| JB3 Validation | Covidien LP | $427,420 | 1 |
| INVOS Peds 7100 | Medtronic, Inc. | $354,191 | 0 |
| Investigator Sponsored Research | Medtronic, Inc. | $326,055 | 0 |
| INVOS | Covidien LP | $206,679 | 1 |
| Investigator Sponsored Research | Covidien LP | $198,533 | 0 |
| INVESTIGATOR SPONSORED RESEARCH | COVIDIEN LP | $181,845 | 0 |
| INVOS | COVIDIEN LP | $152,964 | 1 |
| CLINICAL MODEL FOR EARLY PREDICTORS OF NECROTIZING ENTEROCOLITIS IN NEONATES | Covidien LP | $130,096 | 0 |
| INVOS Adult Jug Bulb | Medtronic, Inc. | $102,880 | 0 |
| RED BLOOD CELL TRANSFUSION AND DIGESTIVE TRACT OXYGENATION IN PRETERM INFANTS | COVIDIEN LP | $83,400 | 0 |
| CEREBRAL OXYGENATION AND AUTOREGULATION IN PRETERM INFANTS | COVIDIEN LP | $57,826 | 0 |
| PM7100 System Performance Evaluation While Detecting Sensor On and Off Features | Covidien LP | $42,760 | 0 |
| ACVOR | COVIDIEN LP | $31,863 | 2 |
| INVOS NIRS Technology Development in the Pediatric Cardiac Catheterization Laboratory | Covidien LP | $31,440 | 0 |
| Equivalence in Backward Compatibility Between the Adult Sensors PMSENS71A and SAFB-SM on INVOSTM 5100C | Covidien LP | $31,086 | 0 |
| Cerebral NIRS Monitoring and Neonatal Outcomes following Birth Asphyxia | Covidien LP | $24,050 | 0 |
| ISR | Covidien LP | $22,752 | 0 |
| Equivalence in Backward Compatibility Between the Adult Sensors PMSENS71A and SAFBSM on INVOSTM 5100C | Covidien LP | $20,000 | 0 |
| Effect of Blood Transfusion Practices on Cerebral and Somatic Oximetry | Covidien LP | $18,603 | 0 |
Top Doctors Receiving Payments for INVOS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Wilmington, NC | $3.8M | 321 |
| , MD | Anesthesiology | Durham, NC | $427,420 | 1 |
| , M.D | Pediatric Critical Care Medicine | Houston, TX | $131,523 | 232 |
| , MD | Anesthesiology | Louisville, CO | $52,354 | 4 |
| , MD | Pediatrics | Saint Louis, MO | $38,672 | 20 |
| , RN, MSN, FNP | Acute Care | Orange, CA | $24,667 | 43 |
| , MD | Anesthesiology | Cleveland, OH | $20,454 | 22 |
| Masahiro Ono | Vascular Surgery | Houston, TX | $20,069 | 3 |
| , MD | Anesthesiology | Richmond, VA | $17,676 | 21 |
| , NNP | Neonatal, Critical Care | Atlanta, GA | $14,823 | 32 |
| , MD | Anesthesiology | Baltimore, MD | $10,587 | 2 |
| , M.D | Anesthesiology | Chicago, IL | $9,238 | 7 |
| , M.D | Anesthesiology | Stony Brook, NY | $8,447 | 10 |
| , MD | Neonatal-Perinatal Medicine | Stony Brook, NY | $7,774 | 19 |
| , M.D | Pediatric Cardiology | Cincinnati, OH | $7,109 | 28 |
| , MD | Anesthesiology | Columbus, OH | $6,000 | 1 |
| , M.D | Critical Care Medicine | Winston Salem, NC | $5,754 | 5 |
| , MD | Pediatric Emergency Medicine | Atlanta, GA | $5,180 | 4 |
| , MD | Anesthesiology | New Haven, CT | $4,980 | 8 |
| , MD | Pain Medicine | Winston-Salem, NC | $4,451 | 7 |
| , M.D | Anesthesiology | Boston, MA | $4,200 | 1 |
| , MD | Pediatric Critical Care Medicine | Kansas City, MO | $2,670 | 2 |
| , MD | Neonatal-Perinatal Medicine | Louisville, KY | $2,242 | 7 |
| , MD | Neurology | Fresno, CA | $2,217 | 4 |
| Juan Rivera Gonzalez | — | San Juan, PR | $2,000 | 1 |
Ad
Manufacturing Companies
- Medtronic, Inc. $2.8M
- Covidien LP $1.5M
- COVIDIEN LP $523,942
Product Information
- Type Device
- Total Payments $4.8M
- Total Doctors 3,284
- Transactions 5,458
About INVOS
INVOS is a device associated with $4.8M in payments to 3,284 healthcare providers, recorded across 5,458 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..
Payment data is available from 2017 to 2024. In 2024, $1.7M was paid across 1,313 transactions to 835 doctors.
The most common payment nature for INVOS is "Unspecified" ($4.2M, 87.1% of total).
INVOS is associated with 20 research studies, including "INVOS CathLab" ($1.7M).